CarlieKennedyThompsonMD

PubMed

• Current Status of Contralateral Prophylactic Mastectomy: Investigating Structural Racial Disparity.
  Amulya Vadlakonda, Joanna Curry, Zihan Gao, Konmal Ali, Nikhil Chervu, Hanjoo Lee, Carlie K Thompson, Peyman Benharash> ;Journal of the American College of Surgeons. 2024 Apr 11
• 1 citations
  Higher risk tumor features are not associated with higher nodal stage in patients with estrogen receptor-positive, node-positive breast cancer.
  Linda Ye, Dennis Rünger, Stephanie A Angarita, Joseph Hadaya, Jennifer L Baker, Minna K Lee, Carlie K Thompson, Deanna J Attai, Maggie L DiNome> ;Breast Cancer Research and Treatment. 2022 Jun 1
• 18 citations
  SAVI SCOUT® localization of metastatic axillary lymph node prior to neoadjuvant chemotherapy for targeted axillary dissection: a pilot study
  Jennifer L. Baker, Farnaz Haji, Amy M. Kusske, Cheryce P. Fischer, Anne C. Hoyt, Carlie K Thompson, Minna K Lee, Deanna J. Attai, Maggie L DiNome> ;Breast Cancer Research and Treatment. 2021 Oct 15
• ASO Visual Abstract: "Going Flat" After Mastectomy: Patient-Reported Outcomes by Online Survey.
  Jennifer L. Baker, Don S. Dizon, Cachet Wenziger, Elani Streja, Carlie K Thompson, Minna K Lee, Maggie L. DiNome, Deanna J. Attai> ;Annals of Surgical Oncology. 2021 Mar 11
• 13 citations
  National trends and predictors of mastectomy with immediate breast reconstruction.
  Ava Mandelbaum, Morcos Nakhla, Young Ji Seo, Vishal Dobaria, Deanna J. Attai, Jennifer L. Baker, Carlie K Thompson, Maggie L. DiNome, Peyman Benharash, Minna K Lee> ;American Journal of Surgery. 2021 Feb 17
• 37 citations
  How patients experience endocrine therapy for breast cancer: an online survey of side effects, adherence, and medical team support.
  Maurice J. Berkowitz, Carlie K Thompson, Laura Zibecchi, Minna K Lee, Elani Streja, Jacob S. Berkowitz, Cachet Wenziger, Jennifer L. Baker, Maggie L. DiNome, Deanna J....> ;Journal of Cancer Survivorship. 2021 Feb 1
• 22 citations
  "Going Flat" After Mastectomy: Patient-Reported Outcomes by Online Survey.
  Jennifer L. Baker, Don S. Dizon, Cachet Wenziger, Elani Streja, Carlie K Thompson, Minna K Lee, Maggie L. DiNome, Deanna J. Attai> ;Annals of Surgical Oncology. 2021 Jan 3
• 12 citations
  Assessing the Burden of Nodal Disease for Breast Cancer Patients with Clinically Positive Nodes: Hope for More Limited Axillary Surgery
  Stephanie A.K. Angarita, Linda Ye, Dennis Rünger, Joseph Hadaya, Jennifer L. Baker, Nicole A. Dawson, Carlie K Thompson, Minna K Lee, Deanna J. Attai, Maggie L. DiNome> ;Annals of Surgical Oncology. 2021 May 1
• 23 citations
  National Trends in Immediate Breast Reconstruction: An Analysis of Implant-Based Versus Autologous Reconstruction After Mastectomy
  Ava Mandelbaum, Carlie K Thompson, Deanna J. Attai, Jennifer L. Baker, Ginger C. Slack, Maggie L. DiNome, Peyman Benharash, Minna K Lee> ;Annals of Surgical Oncology. 2020 Jul 25
• 19 citations
  A comparison of two non-radioactive alternatives to wire for the localization of non-palpable breast cancers
  Minna K Lee, Yas Sanaiha, Amy M. Kusske, Carlie K Thompson, Deanna J. Attai, Jennifer L. Baker, Cheryce P. Fischer, Maggie L. DiNome> ;Breast Cancer Research and Treatment. 2020 May 25
• 13 citations
  Taking a Second Look at Neoadjuvant Endocrine Therapy for the Treatment of Early Stage Estrogen Receptor Positive Breast Cancer During the COVID-19 Outbreak.
  Carlie K Thompson, Minna K Lee, Jennifer L. Baker, Deanna J. Attai, Maggie L. DiNome> ;Annals of Surgery. 2020 May 20
• 47 citations
  Intratumor Heterogeneity of the Estrogen Receptor and the Long-term Risk of Fatal Breast Cancer.
  Linda S. Lindström, Christina Yau, Kamila Czene, Carlie K Thompson, Katherine A. Hoadley, Laura J. van't Veer, Ronald Balassanian, John W. Bishop, Philip M. Carpenter,...> ;Journal of the National Cancer Institute. 2018 Jul 1
• 77 citations
  Use of Molecular Tools to Identify Patients With Indolent Breast Cancers With Ultralow Risk Over 2 Decades
  Laura J. Esserman, Christina Yau, Carlie K Thompson, Laura J. van't Veer, Alexander D. Borowsky, Katherine A. Hoadley, Nicholas P. Tobin, Bo Nordenskjöld, Tommy Fornan...> ;JAMA Oncology. 2017 Nov 1
• 143 citations
  Breast Cancer Screening in the Precision Medicine Era: Risk-Based Screening in a Population-Based Trial
  Yiwey Shieh, Martin Eklund, Lisa Madlensky, S Sawyer, Carlie K Thompson, Allison Stover Fiscalini, Elad Ziv, Laura J. van't Veer, Laura J. Esserman, Jeffrey A. Tice> ;Journal of the National Cancer Institute. 2017 Jan 27
• Effect of MRI on the management of ductal carcinoma in situ of the breast.
  Pilewskie, M.,Kennedy, C.,Shappell, C.,Helenowski, I.,Scholtens, D.,Hansen, N.,Bethke, K.,Jeruss, J.,Karstaedt, P.,Khan, S. A.> ;Ann. Surg. Oncol.. 2013 May
• Neoadjuvant versus adjuvant chemotherapy for triple negative breast cancer.
  Kennedy, C.R., Gao, F., Margenthaler, J.A.> ;J Surg Res. 2010 Sep
• Join now to see all

Journal Articles

• The WISDOM Study: breaking the deadlock in the breast cancer screening debate.  
  Esserman LJ, Anton-Culver H, Borowsky A, Brain S, Cink T, Crawford B, Eklund M, Esserman L, Fenton J, Heditsian D, Hiatt RA, Hogarth M, Kaplan C, Koenig B, LaCroix A, ..., NPJ Breast Cancer, 9/13/2017
• Putting the Great Mammography Debate to rest  
  Thompson CK, Eklund M, Esserman LJ, Am J Hematol Oncol, 1/1/2015

Abstracts/Posters

• The past, present and future of the neoadjuvant treatment of breast cancer
  Thompson CK, Grand Rounds, Cedars-Sinai Medical Center, Los Angeles, CA, 1/1/2018
• Axillary staging is associated with better outcomes in women with small, estrogen-receptor positive breast cancers
  Thompson CK, Hunter-Squires J, Carlson KA, Kim S, Amersi F, Giuliano AE, Chung A, American Society of Breast Surgeons Annual Meeting, Orlando, FL, 1/1/2018
• Accuracy of pre-surgical imaging to guide surgical resection in patients with invasive breast cancer treated with neoadjuvant chemotherapy
  Carlson KA, Siegel E, Thompson CK, Kim S, Amersi F, Giuliano A, Chung A, American Society of Breast Surgeons Annual Meeting, Orlando, FL, 1/1/2018
• Comparison of survival outcomes in node-negative T1a and T1b high-risk breast cancer treated with and without adjuvant chemotherapy
  Carlson KA, Thompson CK, Kim S, Bao J, Amersi F, Giuliano A, Chung A, Society of Surgical Oncology Annual Cancer Symposium, Chicago, IL, 1/1/2018
• Are we overtreating DCIS?
  Thompson CK, Southern California Chapter of the American College of Surgeons Annual Scientific Meeting, Santa Barbara, CA, 1/1/2018
• The history of women in medicine
  Thompson CK, Grand Rounds, UCSF, San Francisco, CA, 1/1/2016
• Phenotype and immunophenotype analysis of gene expression defined �indolent risk� breast cancers
  Borowsky A, Thompson CK, Balassanian R, Yau C, Chen Y, Krings G, Nordenskjold B, Stal O, Fornander T, Esserman LJ, van�t Veer LJ, Lindstrom LS, United States and Canada Academy of Pathologists Annual Meeting, Seattle, WA, 1/1/2016
• Interobserver agreement of breast cancer IHC4 after �Score the Core� training
  Borowsky A, Balassanian R, Yau C, Engelberg JA, Thompson CK, Bishop JW, Cardiff R, Carpenter PM, Chen Y, Datnow B, Hasteh F, Krings G, Lin F, Zhang Y, Lindstrom L, United States and Canada Academy of Pathologists Annual Meeting, Seattle, WA, 1/1/2016
• Breast cancer screening in the precision medicine era
  Thompson CK, Fiscalini AS, Donnellan P, Kaplan CP, Madlensky L, Eklund M, Ziv E, van't Veer LJ, Tice JA, Esserman LJ, SABCS, San Antonio, TX, 1/1/2015
• A pilot feasibility study of the WISDOM study, a preference-tolerant randomized controlled trial evaluating a risk-based breast cancer screening strategy
  Narasimmaraj PR, Stover Fiscalini A, Kaplan CP, van't Veer LJ, Hallada AM, Thompson CK, Theiner S, Borowsky A, Naeim A, Anton-Culver H, LaCroix A, Athena Breast Health..., San Antonio Breast Cancer Symposium, San Antonio, TX, 1/1/2015
• Identification of tumors with an indolent disease course: MammaPrint Ultralow signature validation in a retrospective analysis of Swedish randomized tamoxifen trial (STO)
  Esserman LJ, Thompson CK, Yau C, van�t Veer LJ, Borowsky AD, Tobin NP, Nordenskjold B, Fornander T, Stal O, Benz CC, Lindstrom LS, San Antonio Breast Cancer Symposium, San Antonio, TX, 1/1/2015
• Intra-tumor heterogeneity of the estrogen receptor predicts less benefit from tamoxifen therapy and poor long-term breast cancer patient survival � retrospective analy...
  Lindstrom LS, Yau C, Czene K, Thompson CK, van�t Veer LJ, Nordenskjold B, Stal O, Fornander T, Benz CC, Borowsky A, Esserman LJ, European Cancer Congress, Vienna, Austria, 1/1/2015
• The rise in the rates of contralateral prophylactic mastectomy: can we personalize this decision?
  Thompson CK, UCSF Postgraduate Course, 1/1/2015
• The feasibility of performing a preference-tolerant randomized controlled trial of personalized versus annual breast cancer screening
  Thompson CK, Kaplan CP, Wattles AG, Fiscalini AS, Tice, JA, Eklund M, Esserman LJ, Society of Surgical Oncology Annual Cancer Symposium, Houston, TX, 1/1/2015
• The aggregate number of false-positive recalls and biopsies performed under different screening strategies in the US
  Thompson CK, O�Donoghue C, Ozanne E, Eklund M, Esserman L, SABCS, San Antonio, TX, 1/1/2014
• MammaPrint accurately predicts long-term survival (25 years) and adjuvant tamoxifen therapy benefit lymph node negative patients
  Lindstrom L, Benz C, Yau C, van�t Veer L, Thompson CK, Esserman L, San Antonio Breast Cancer Symposium, San Antonio, TX, 1/1/2014
• Improving the Care of Septic Patients: A Baseline Analysis and Quality Improvement Initiative
  Rajaram R, Kennedy C, Schwulst S, Bilimoria KY, NRSA Trainee�s Research Conference, San Diego, CA, 1/1/2014
• Striatal ascorbate-release dysfunction in murine models of Huntington's
  Dorner J, Barton S, Kennedy C, Murphy-Nakhnikian A, Rebec G, Society for Neuroscience, San Diego, CA, 1/1/2004
• Join now to see all

Other

• The effects of ceftriaxone on striatal ascorbate in Huntington's disease transgenic mice 
  Kennedy C, Thesis
  Indiana University